Terms: = Lung cancer AND SFPQ, PSF, 6421, ENSG00000116560, P23246 AND Treatment
10 results:
1. Insensitivity of oncogenic EGFR R776L mutation to EGFR inhibitors in lung cancer.
Wang Y; Hu C; Yu H; Hu J; Zhou Z; Fu N; Huang X; Kong F; Wang W; Liu J
Lung Cancer; 2024 Mar; 189():107495. PubMed ID: 38335691
[TBL] [Abstract] [Full Text] [Related]
2. Splicing factor proline- and glutamine-rich regulates cytotoxic T lymphocytes-mediated cytotoxicity on non-small cell lung cancer by directly binding to PD-L1 3'UTR.
Pan Y; Cheng Y
Medicine (Baltimore); 2023 Nov; 102(45):e35837. PubMed ID: 37960731
[TBL] [Abstract] [Full Text] [Related]
3. Likely uptake of a future a lung cancer screening programme in Hodgkin lymphoma survivors: a questionnaire study.
Broadbent R; Armitage CJ; Crosbie P; Radford J; Linton K
BMC Pulm Med; 2022 Apr; 22(1):165. PubMed ID: 35484621
[TBL] [Abstract] [Full Text] [Related]
4. Phantom and clinical assessment of small pulmonary nodules using Q.Clear reconstruction on a silicon-photomultiplier-based time-of-flight PET/CT system.
Wu Z; Guo B; Huang B; Hao X; Wu P; Zhao B; Qin Z; Xie J; Li S
Sci Rep; 2021 May; 11(1):10328. PubMed ID: 33990659
[TBL] [Abstract] [Full Text] [Related]
5. ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis.
Elliott J; Bai Z; Hsieh SC; Kelly SE; Chen L; Skidmore B; Yousef S; Zheng C; Stewart DJ; Wells GA
PLoS One; 2020; 15(2):e0229179. PubMed ID: 32074131
[TBL] [Abstract] [Full Text] [Related]
6. 17β-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner.
Fang D; Yang H; Lin J; Teng Y; Jiang Y; Chen J; Li Y
Biochem Biophys Res Commun; 2015 Feb; 457(4):500-6. PubMed ID: 25592968
[TBL] [Abstract] [Full Text] [Related]
7. ARCHERRT - a GPU-based and photon-electron coupled Monte Carlo dose computing engine for radiation therapy: software development and application to helical tomotherapy.
Su L; Yang Y; Bednarz B; Sterpin E; Du X; Liu T; Ji W; Xu XG
Med Phys; 2014 Jul; 41(7):071709. PubMed ID: 24989378
[TBL] [Abstract] [Full Text] [Related]
8. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.
Lasnon C; Desmonts C; Quak E; Gervais R; Do P; Dubos-Arvis C; Aide N
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):985-96. PubMed ID: 23564036
[TBL] [Abstract] [Full Text] [Related]
9. Partial volume correction strategies for quantitative FDG PET in oncology.
Hoetjes NJ; van Velden FH; Hoekstra OS; Hoekstra CJ; Krak NC; Lammertsma AA; Boellaard R
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1679-87. PubMed ID: 20422184
[TBL] [Abstract] [Full Text] [Related]
10. SBRT of lung tumours: Monte Carlo simulation with PENELOPE of dose distributions including respiratory motion and comparison with different treatment planning systems.
Panettieri V; Wennberg B; Gagliardi G; Duch MA; Ginjaume M; Lax I
Phys Med Biol; 2007 Jul; 52(14):4265-81. PubMed ID: 17664607
[TBL] [Abstract] [Full Text] [Related]
